Ophthalmology | Epigenetics | Lasik | Nutrition
I have expanded my practice into the prevention and treatment of eye diseases using epigenetics. What is so exciting about this is that in the process of preventing and treating eye diseases we can prevent and treat other diseases as well.
Thanks to the human genome project we can do more to prevent diseases of the eye such as macular degeneration, diabetic retinopathy, glaucoma, and cataract. The key idea is that we are treating at the cellular level because ultimately all diseases are manifestations of cellular dysfunction. The same science can benefit many other conditions (such as migraine) for the exact same reason. The science involved in this effort exists at xR, an organization I founded. On this site you can learn a great deal about this by starting with the "Epigenetics" link.
My prior accomplishments included being part of the earliest FDA trials on PRK in 1988. In 1994 I developed my own approach to Lasik Eye Surgery in conjunction with the FDA. I was the first surgeon in Ohio to do Lasik (2nd in the USA) and chosen to win an international award on Lasik in 1998. I participated in the development of a silicone inside the eye contact lenses. We were first to implement the concept of a small hole in the center of a posterior chamber lenses to simplify surgical implantation. That small hole is currently being used in Europe. One of my favorite ideas had to do with an attempt to treat macular degeneration by activating an enzyme called thrombin with light inside the eye. It resulted in a PhD thesis for a graduate student at Duke. Prior to Duke I studied medicine at Cornell Medical College where I worked with a great team of doctors treating retinoblastoma. Before that I studied engineering at Case Western Reserve University. My career has always been to innovate new ideas to improve the quality of life of my patients. - Dr. Rozakis